| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CONFIRM-HF: Novel Approach Treating ID Improved Function, Symptoms, and QOL
|
Mosley, Mary
|
|
2014
|
|
27 |
p. 14-15
|
artikel
|
| 2 |
COPPS-2: Colchicine Reduced PPS in Cardiac Surgery Patients
|
Mosley, Mary
|
|
2014
|
|
27 |
p. 15-16
|
artikel
|
| 3 |
Darapladib Ineffective at Reducing Major Coronary Events after ACS
|
Parry, Nicola
|
|
2014
|
|
27 |
p. 17-17
|
artikel
|
| 4 |
ENGAGE AF-TIMI 48: Tailoring Edoxaban Dose Preserves Drug Efficacy and Safety
|
Hoyle, Brian
|
|
2014
|
|
27 |
p. 25-27
|
artikel
|
| 5 |
FAME 2: FFR—Guided PCI Reduces Urgent Revascularization
|
Hoyle, Brian
|
|
2014
|
|
27 |
p. 30-30
|
artikel
|
| 6 |
FAMOUS NSTEMI: FFR-Guided Management of NSTEMI Reduces PCI and CABG
|
Nichols, Emma Hitt
|
|
2014
|
|
27 |
p. 27-28
|
artikel
|
| 7 |
IBIS-4: High-Dose Rosuvastatin Reduces Plaque Burden in Patients with STEMI
|
Parry, Nicola
|
|
2014
|
|
27 |
p. 19-24
|
artikel
|
| 8 |
Innovations in ACS Treatment
|
Parry, Nicola
|
|
2014
|
|
27 |
p. 5-6
|
artikel
|
| 9 |
NECTAR-HF: Cardiac Remodeling Not Reduced with VNS
|
Mosley, Mary
|
|
2014
|
|
27 |
p. 12-13
|
artikel
|
| 10 |
NO Fails to Reduce Myocardial IS: NOMI Results
|
Nichols, Emma Hitt
|
|
2014
|
|
27 |
p. 24-24
|
artikel
|
| 11 |
ODYSSEY COMBO II: Alirocumab Significantly Improves Cholesterol Levels in Patients with High CV Risk
|
Parry, Nicola
|
|
2014
|
|
27 |
p. 10-11
|
artikel
|
| 12 |
ODYSSEY FH I and FH II: Alirocumab Significantly Improves Cholesterol Levels in Patients with HeFH
|
Parry, Nicola
|
|
2014
|
|
27 |
p. 18-19
|
artikel
|
| 13 |
Overview of 2014 ESC Guidelines
|
Hoyle, Brian
|
|
2014
|
|
27 |
p. 31-34
|
artikel
|
| 14 |
PARADIGM-HF: Novel Drug Reduced Outcomes, Improved Symptoms Better Than ACE Inhibition
|
Mosley, Mary
|
|
2014
|
|
27 |
p. 11-12
|
artikel
|
| 15 |
POPE-2: No Benefit with Colchicine to Reduce Persistent Postoperative Pericardial Effusion
|
Mosley, Mary
|
|
2014
|
|
27 |
p. 15-15
|
artikel
|
| 16 |
Prehospital Ticagrelor Reduces Stent Thrombosis in STEMI
|
Nichols, Emma Hitt
|
|
2014
|
|
27 |
p. 17-18
|
artikel
|
| 17 |
Reducing CV Outcomes in Patients with AF
|
Hoyle, Brian
|
|
2014
|
|
27 |
p. 35-37
|
artikel
|
| 18 |
SIGNIFY: Treatment with Ivabradine Does Not Improve Outcomes and May Increase Risk in Patients with Angina
|
Mosley, Mary
|
|
2014
|
|
27 |
p. 13-14
|
artikel
|
| 19 |
STABILITY: Darapladib and Lp-PLA2 Levels in Treatment of Atherosclerosis
|
Hoyle, Brian
|
|
2014
|
|
27 |
p. 28-29
|
artikel
|
| 20 |
Strategies to Prevent Stroke in Patients with AF
|
Mosley, Mary
|
|
2014
|
|
27 |
p. 7-9
|
artikel
|
| 21 |
TRO40303 Lacks Protective Effect in PCI: Results from MITOCARE
|
Nichols, Emma Hitt
|
|
2014
|
|
27 |
p. 24-25
|
artikel
|
| 22 |
Update on Resistant Hypertension
|
Hoyle, Brian
|
|
2014
|
|
27 |
p. 38-39
|
artikel
|
| 23 |
X-VeRT Results: Rivaroxaban is Safe and Effective for Cardioversion in AF
|
Parry, Nicola
|
|
2014
|
|
27 |
p. 27-27
|
artikel
|
Tijdschrift beschrijving